Foresite Capital Management VI LLC Diversified Active

Name: Foresite Capital Management VI LLC Q2 2025 13F Filing | 13F Explorer
Creator: Foresite Capital Management VI LLC
Published: 2025-08-12

Location: West Hollywood, CA

CIK: 0002013341 · Show all filings

Period: Q2 2025 (← Previous) (Next →)

Filing Date: Aug 12, 2025

Total Value: $178M (100.0% shares, 0.0% debt)

Holdings (20)

CGON CG Oncology, Inc. 32.5%

Value $57.76M Shares 2,221,474 Est. Cost $34.21 Unrealized -29.6%

CNTA Centessa Pharmaceuticals Inc 9.3%

Value $16.47M Shares 1,253,379 Est. Cost $16.75 Unrealized —

— Akero Therapeutics Inc 7.3%

Value $13.07M Shares 244,900 Est. Cost $27.82 Unrealized —

ALMS Alumis Inc 7.2%

Value $12.74M Shares 4,247,670 Est. Cost $9.97 Unrealized -52.6%

RAPT Rapt Therapeutics Inc 7.0%

Value $12.5M Shares 1,562,500 Est. Cost $7.63 Unrealized 0.0%

BCAX Bicara Therapeutics Inc 5.0%

Value $8.819M Shares 949,260 Est. Cost $20.81 Unrealized -42.7%

EWTX Edgewise Therapeutics Inc 4.3%

Value $7.669M Shares 585,000 Est. Cost $31.84 Unrealized -54.7%

HNGE Hinge Health Inc 3.9%

Value $6.986M Shares 135,000 Est. Cost $40.42 Unrealized 0.0%

CRVS Corvus Pharmaceuticals Inc 3.9%

Value $6.925M Shares 1,731,233 Est. Cost $7.13 Unrealized -49.0%

KYMR Kymera Therapeutics Inc 3.6%

Value $6.386M Shares 146,332 Est. Cost $45.17 Unrealized -23.8%

VSTM Verastem Inc 3.0%

Value $5.298M Shares 1,276,520 Est. Cost $6.26 Unrealized 0.0%

XENE Xenon Pharmaceuticals Inc 2.8%

Value $5.008M Shares 160,000 Est. Cost $32.62 Unrealized 0.0%

CGEM Cullinan Therapeutics Inc 2.5%

Value $4.473M Shares 594,025 Est. Cost $14.37 Unrealized -44.1%

GPCR Structure Therapeutics Inc 2.4%

Value $4.355M Shares 210,000 Est. Cost $27.12 Unrealized —

ALLO Allogene Therapeutics Inc 1.8%

Value $3.249M Shares 2,875,357 Est. Cost $2.47 Unrealized -46.1%

IDYA Ideaya Biosciences Inc 1.7%

Value $3.037M Shares 144,468 Est. Cost $19.19 Unrealized 0.0%

RNAM Avidity Biosciences Inc 0.6%

Value $1.136M Shares 40,000 Est. Cost $29.81 Unrealized 0.0%

SYRE Spyre Therapeutics Inc 0.6%

Value $1.048M Shares 70,000 Est. Cost $14.80 Unrealized 0.0%

CASIF Casi Pharmaceuticals Inc 0.5%

Value $929K Shares 787,121 Est. Cost $4.74 Unrealized -61.4%

VRDN Viridian Therapeutics, Inc 0.0%

Value $27,597 Shares 1,974 Est. Cost $21.74 Unrealized -37.6%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
CGON	CG Oncology, Inc.	2,221,474	$57.76M	32.5%	$34.21	-29.6%	COM	156944100
CNTA	Centessa Pharmaceuticals Inc	1,253,379	$16.47M	9.3%	$16.75	—	SPONSORED ADS	152309100
—	Akero Therapeutics Inc	244,900	$13.07M	7.3%	$27.82	—	COM	00973Y108
ALMS	Alumis Inc	4,247,670	$12.74M	7.2%	$9.97	-52.6%	COM	022307102
RAPT	Rapt Therapeutics Inc	1,562,500	$12.5M	7.0%	$7.63	0.0%	COM	75382E208
BCAX	Bicara Therapeutics Inc	949,260	$8.819M	5.0%	$20.81	-42.7%	COM	055477103
EWTX	Edgewise Therapeutics Inc	585,000	$7.669M	4.3%	$31.84	-54.7%	COM	28036F105
HNGE	Hinge Health Inc	135,000	$6.986M	3.9%	$40.42	0.0%	CL A	433313103
CRVS	Corvus Pharmaceuticals Inc	1,731,233	$6.925M	3.9%	$7.13	-49.0%	COM	221015100
KYMR	Kymera Therapeutics Inc	146,332	$6.386M	3.6%	$45.17	-23.8%	COM	501575104
VSTM	Verastem Inc	1,276,520	$5.298M	3.0%	$6.26	0.0%	COM	92337C203
XENE	Xenon Pharmaceuticals Inc	160,000	$5.008M	2.8%	$32.62	0.0%	COM	98420N105
CGEM	Cullinan Therapeutics Inc	594,025	$4.473M	2.5%	$14.37	-44.1%	COM	230031106
GPCR	Structure Therapeutics Inc	210,000	$4.355M	2.4%	$27.12	—	SPONSORED ADS	86366E106
ALLO	Allogene Therapeutics Inc	2,875,357	$3.249M	1.8%	$2.47	-46.1%	COM	019770106
IDYA	Ideaya Biosciences Inc	144,468	$3.037M	1.7%	$19.19	0.0%	COM	45166A102
RNAM	Avidity Biosciences Inc	40,000	$1.136M	0.6%	$29.81	0.0%	COM	05370A108
SYRE	Spyre Therapeutics Inc	70,000	$1.048M	0.6%	$14.80	0.0%	COM	00773J202
CASIF	Casi Pharmaceuticals Inc	787,121	$929K	0.5%	$4.74	-61.4%	ORD SHS	G1933S101
VRDN	Viridian Therapeutics, Inc	1,974	$27,597	0.0%	$21.74	-37.6%	COM	92790C104